173 related articles for article (PubMed ID: 15656828)
1. Localized scleroderma: response to occlusive treatment with tacrolimus ointment.
Mancuso G; Berdondini RM
Br J Dermatol; 2005 Jan; 152(1):180-2. PubMed ID: 15656828
[No Abstract] [Full Text] [Related]
2. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study.
Stefanaki C; Stefanaki K; Kontochristopoulos G; Antoniou C; Stratigos A; Nicolaidou E; Gregoriou S; Katsambas A
J Dermatol; 2008 Nov; 35(11):712-8. PubMed ID: 19120765
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus in the treatment of localized scleroderma.
Mancuso G; Berdondini RM
Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.
Kroft EB; Groeneveld TJ; Seyger MM; de Jong EM
Am J Clin Dermatol; 2009; 10(3):181-7. PubMed ID: 19354332
[TBL] [Abstract][Full Text] [Related]
5. Generalized morphea successfully treated with tacrolimus 0.1% ointment.
Cantisani C; Miraglia E; Richetta AG; Mattozzi C; Calvieri S
J Drugs Dermatol; 2013 Jan; 12(1):14-5. PubMed ID: 23377321
[No Abstract] [Full Text] [Related]
6. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
[No Abstract] [Full Text] [Related]
7. Annular erythema responding to tacrolimus ointment.
Rao NG; Pariser RJ
J Drugs Dermatol; 2003 Aug; 2(4):421-4. PubMed ID: 12884468
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of vitiligo with 0.1% tacrolimus ointment.
Travis LB; Weinberg JM; Silverberg NB
Arch Dermatol; 2003 May; 139(5):571-4; discussion 573. PubMed ID: 12756092
[No Abstract] [Full Text] [Related]
9. 0.1% tacrolimus ointment for the treatment of intertrigo.
Chapman MS; Brown JM; Linowski GJ
Arch Dermatol; 2005 Jun; 141(6):787. PubMed ID: 15967933
[No Abstract] [Full Text] [Related]
10. Rosacea/acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment.
Sehgal VN; Sharma S; Sardana K
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1366-8. PubMed ID: 18435734
[No Abstract] [Full Text] [Related]
11. Treatment of localized lichen myxedematosus of discrete type with tacrolimus ointment.
Rongioletti F; Zaccaria E; Cozzani E; Parodi A
J Am Acad Dermatol; 2008 Mar; 58(3):530-2. PubMed ID: 18280368
[No Abstract] [Full Text] [Related]
12. Angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment.
Wang S; Li W
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):237. PubMed ID: 19686258
[No Abstract] [Full Text] [Related]
13. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
Naylor M; Elmets C; Jaracz E; Rico JM
J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
[TBL] [Abstract][Full Text] [Related]
14. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
Hengge UR; Krause W; Hofmann H; Stadler R; Gross G; Meurer M; Brinkmeier T; Frosch P; Moll I; Fritsch P; Müller K; Meykadeh N; Marini A; Ruzicka T; Gollnick H
Br J Dermatol; 2006 Nov; 155(5):1021-8. PubMed ID: 17034535
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study.
Reitamo S; Ortonne JP; Sand C; Bos J; Cambazard F; Bieber T; Grønhøj-Larsen C; Rustin M; Fölster-Holst R; Schuttelaar M;
Acta Derm Venereol; 2007; 87(5):406-12. PubMed ID: 17721647
[TBL] [Abstract][Full Text] [Related]
18. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
Hartmann A; Bröcker EB; Hamm H
Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment.
Clayton TH; Harrison PV
Br J Dermatol; 2005 Mar; 152(3):581-2. PubMed ID: 15787840
[No Abstract] [Full Text] [Related]
20. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E;
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
